News
As advances in artificial intelligence technology continue to offer enticing benefits to industries across the board, pharma ...
For $10 billion, Merck is acquiring a promising healthcare company which is in the early stages of its growth. Key to its ...
StockStory.org on MSN1h
Abbott Laboratories’s (NYSE:ABT) Q2 Sales Top EstimatesHealthcare product and device company Abbott Laboratories (NYSE:ABT) in Q2 CY2025, with sales up 7.4% year on year to $11.14 ...
The airline reset its profit guidance for the year, citing improved travel appetite after economic turmoil and flight disruptions depressed bookings this spring. Coca-Cola says more details are to ...
Indian equity markets opened lower, mirroring muted Asian sentiment amid concerns over the US Federal Reserve Chair. While some sectors like Auto and Pharma saw gains, IT faced headwinds due to ...
Johnson & Johnson stands alone as a leader across the major healthcare industries. It maintains a diverse revenue base, a developing research pipeline, and exceptional cash flow generation that ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced a strategic restructuring plan ...
J&J (NYSE:JNJ) stock surges rallying peers despite Trump's latest tariff threats on pharma as the company posts a quarterly ...
SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...
Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...
Trackonomy reports cargo theft is a rising issue in supply chains, costing billions while advanced technology helps combat ...
Now, after setting an innovative medicines sales record in the year’s second quarter, it appears J&J’s confidence was well placed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results